What is the recommended management for a dengue patient with bilateral pleural effusions (approximately 300 mL on the right and 100 mL on the left)?

Management of Dengue with Bilateral Pleural Effusion

In dengue patients with bilateral pleural effusions (300 mL right, 100 mL left), conservative management with careful fluid resuscitation is the primary approach—do NOT routinely drain these effusions as they represent plasma leakage that will spontaneously resolve during the recovery phase.

Understanding Dengue-Related Pleural Effusions

Dengue pleural effusions are fundamentally different from infectious pleural effusions. They result from increased capillary permeability and plasma leakage, not infection 1, 2. These effusions:

• Occur during the critical phase (typically days 3-7 of illness)
• Are transudative in nature
• Resolve spontaneously during the recovery phase
• Should NOT be treated like bacterial parapneumonic effusions

Critical distinction: The pleural effusion guidelines 3, 4 you might reference are for infectious/parapneumonic effusions requiring drainage—this does NOT apply to dengue effusions.

Primary Management Strategy

1. Fluid Management is Key

Use crystalloids as first-line fluid replacement 1, 2, 5:

• Normal saline or Ringer's lactate
• Judicious administration to avoid both under- and over-resuscitation
• Monitor for warning signs of fluid overload

Reserve colloids for severe dengue shock syndrome 1:

• Only when pulse pressure <10 mmHg (severe shock)
• Colloids may benefit children with severe dengue shock
• For moderate shock (pulse pressure 10-20 mmHg), crystalloids and colloids have similar outcomes

2. Critical Monitoring Parameters

Assess for adequate tissue perfusion 1:

• Normal capillary refill time (<2-3 seconds in adults)
• Absence of skin mottling
• Warm, dry extremities
• Well-felt peripheral pulses
• Normal mental status
• Urine output ≥0.5 mL/kg/hour (adults)

3. When to Worry About Fluid Overload

Major pitfall: Over-resuscitation with crystalloids in patients who already have third-space fluid accumulation can lead to recovery-phase pulmonary edema 6. Watch for:

• Extended neck veins
• Lung crepitations/crackles
• Third or fourth heart sound
• Positive hepatojugular reflux

If these signs develop, reduce IV fluids and consider diuretics 6.

What NOT to Do

Do NOT perform thoracentesis or chest tube drainage for dengue pleural effusions unless:

• There is secondary bacterial infection (rare, would show fever persisting beyond day 7-10, purulent fluid)
• Massive effusion causing severe respiratory compromise (extremely rare)
• The effusions are enlarging during the recovery phase (suggests alternative diagnosis)

The BTS guidelines recommending drainage 3, 4 apply to bacterial pleural infections, not dengue. Draining dengue effusions:

• Provides no benefit (fluid will re-accumulate from ongoing plasma leakage)
• Risks complications (bleeding due to thrombocytopenia, infection)
• Delays recognition of the true problem (inadequate fluid resuscitation vs. fluid overload)

Clinical Algorithm

Step 1: Confirm dengue diagnosis (NS1 antigen days 1-5, IgM/IgG serology after day 5) 7

Step 2: Determine disease phase and severity 2, 5:

• Febrile phase (days 1-3): Supportive care, oral fluids if tolerated
• Critical phase (days 3-7): Risk of shock, plasma leakage peaks
• Recovery phase (days 7-10): Effusions reabsorb, risk of fluid overload

Step 3: Assess for warning signs requiring hospitalization 5, 7:

• Abdominal pain/tenderness
• Persistent vomiting
• Clinical fluid accumulation (ascites, pleural effusion)
• Mucosal bleeding
• Lethargy/restlessness
• Liver enlargement >2 cm
• Rising hematocrit with falling platelets

Step 4: Fluid management based on hemodynamic status 1, 2, 5:

• No shock: Maintenance IV fluids (crystalloids), close monitoring
• Compensated shock: Crystalloid bolus 10-20 mL/kg over 1 hour, reassess
• Hypotensive shock: Crystalloid bolus 20 mL/kg over 15-30 minutes, repeat if needed
• Refractory shock: Consider colloids (if pulse pressure <10 mmHg) or vasopressors (dopamine or epinephrine) 1

Step 5: Monitor for complications 2, 7, 8:

• Severe bleeding (platelet transfusion if active bleeding, NOT prophylactic)
• Organ impairment (hepatitis, encephalopathy, myocarditis)
• Fluid overload during recovery phase

Special Considerations

Elderly patients: Higher risk of atypical presentations and complications including pericardial effusion 9, 10. Maintain high index of suspicion and consider early imaging.

Hemophagocytic lymphohistiocytosis: Rare but potentially fatal complication requiring steroids or IVIG 2. Suspect if persistent fever beyond day 7-10 with cytopenias and hyperferritinemia.

Evidence Quality Note

The strongest evidence for dengue management comes from WHO guidelines (2009) and recent systematic reviews 2, 5, 7, 11. The key insight from 6 regarding crystalloid-induced pulmonary edema in patients with pre-existing third-space losses is particularly relevant to your case. The BTS pleural effusion guidelines 3, 4, while high-quality, address bacterial infections and should not be applied to dengue effusions.

Bottom line: Your patient's bilateral pleural effusions are expected manifestations of dengue plasma leakage. Focus on optimizing fluid balance—enough to maintain perfusion, not so much that you cause pulmonary edema during recovery. The effusions will resolve on their own.